Skip to main content
  • jacquelyne-gaddy-jacob-stein-new-diversity-curriculum

    Hematology/Oncology Diversity and Inclusion Initiatives

    UNC Lineberger Comprehensive Cancer Center Equity Council Four members of the Department of Medicine are working to bring diversity, equity and inclusion principles into critical areas of UNC Lineberger. “This is a group of 14 faculty, graduate students, and staff–and we’re in the process of identifying patients and community members–coming together to develop a system that mea … Read more

  • Frank-Cassie-dvt-clinic-cbs-17

    Unusual Accident, Blood Clot Diagnosis Leads Leasburg Woman to UNC’s DVT Clinic

    A Leasburg woman is grateful to be back on her feet after months of surgeries and rehabilitation.  While on a cross-country vacation, an unusual accident left her with a huge gash in her leg and swelling that wouldn’t go down. UNC’s hematology specialists determined blood clots were behind the swelling. In a recent CBS-17 news report, Cassi Frank, MMSc, PA-C, with UNC’s Deep Vein … Read more

  • September- Grants and Funding

    Department of Medicine Grants & Funding: September 1 – September 30, 2021

    Division of Gastroenterology and Hepatology Andrea Azcarate-Peril, PhD, received an NC TraCS pilot grant award. Division of Geriatric Medicine Joshua Niznik, PharmD, PhD, received an NC TraCS pilot grant award. UNC’s Center for Aging and Health received a two-year Health Resources and Services Administration (HRSA), Department of Health and Human Services grant (with University o … Read more

  • Jon Serody, MD

    Serody Receives Grant to Evaluate Epigenetic Changes in Innate Immune Cells During Stem Cell Transplantation

    Jonathan Serody, MD, the Elizabeth Thomas Professor of Medicine, Microbiology and Immunology, and chief of the Division of Hematology, received an NIH (NHLBI) R01 grant of $3.4M to evaluate epigenetic changes in innate lymphoid cells as a mediator of acute Graft-Versus-Host Disease (GvHD) after stem cell transplantation. The grant is in collaboration with Samantha Pattenden, PhD, … Read more

  • Zeidner-Serody

    Immunotherapy After High-Dose Chemotherapy Leads to Favorable Outcomes in Acute Myeloid Leukemia

    A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer. The findings were published in Blood Cancer Dis … Read more

  • Shakira_Grant-1-200x300

    Grant Receives $200,000 to Study Impact of Multiple Myeloma on Older Adult Patients, Care Partners

    The National Institute on Aging has awarded Shakira Grant, MBBS, and the UNC Center for Aging and Health a 2-year, $200,000 grant to study the illness and treatment experiences and functional trajectories of older adults with multiple myeloma and their care partners. Grant is assistant professor in the divisions of hematology and geriatric medicine. Multiple myeloma is a disease … Read more

  • davis-phillips-josh-zeidner

    Emerging Therapies For AML With Myelodysplasia-Related Changes: Slowly But Surely Moving the Needle

    Patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) have historically poor outcomes with conventional chemotherapy regimens. Davis Phillips, MD, internal medicine resident, and Josh Zeidner, MD, associate professor of medicine in the division of hematology, published an article that reviews the data for existing therapeutic options for patients with … Read more

  • 21 SCD Conference vs 3

    Sickle Cell Disease Conference: Moving On – A Post COVID Look at Sickle Cell Disease, September 24-25, 2021

    The 9th Annual Sickle Cell Disease Conference encompasses two virtual sessions September 24 and 25, 2021, from 10 a.m. – 12 p.m. This conference is a joint activity between the UNC Sickle Cell Disease Program and Duke University School of Nursing. Session one on September 24 will provide an update on the latest evidence in sickle cell management, including new FDA-approved pharma … Read more

  • Joshua-zeidner

    Zeidner Explains Transformation to AML in Higher-Risk MDS On OncLive.

    Joshua F. Zeidner, MD, associate professor of medicine in the division of hematology, discussed the risk of transformation to acute myeloid leukemia (AML) in higher-risk myelodysplastic syndromes (HR-MDS), recently on OncLiveTV. Watch OncLive TV.  

  • Natalie Grover, MD

    Promising Therapy For Patients With Relapsed/Refractory Hodgkin Lymphoma

    Natalie Grover, MD, assistant professor in the division of hematology and clinical director of the cell therapy program in the Lineberger Comprehensive Cancer Center, discusses her research on anti-CD30 CAR-T therapy for patients with relapsed/refractory Hodgkin lymphoma in a new video featured on the Oncology Learning Network. Following is an excerpt from the transcript: “CAR-T … Read more

  • April- Grants and Funding

    Department of Medicine Grants & Funding: April 1 – April 30, 2021

    Division of Geriatric Medicine John Batsis, MD, was awarded $225,000 from the NIH’s National Institute on Aging to develop and test a remote-sensing resistance band exercise system with a team of researchers from Dartmouth. Joshua Niznik, PharmD, PhD, was awarded a 5-year K08 Mentored Clinical Scientist Development Award by the NIH’s National Institute on Aging for “Deprescribing … Read more

  • sickle-cell-clot

    Pawlinski, Key Awarded $2.8 Million Grant To Study VTE in Sickle Cell Disease

    Rafal Pawlinski, PhD, the Lenvil Lee Rothrock Distinguished Professor of Medicine, and Nigel Key, MD, the Harold R. Roberts Distinguished Professor, both professors in the department of medicine’s division of hematology and members of the UNC Blood Research Center, have been awarded a $2.8 million, 4-year R01 grant from the NIH-NHLBI to investigate the mechanism of venous thrombo … Read more